Skip to main content

Editorial & Research Team

› Senior Editors

Karen Bernstein, Ph.D., Co-Founder, Chairman & Editor-in-Chief
Karen has been writing and publishing on biotechnology since 1987. She holds a Ph.D. in political science from Stanford University and a B.A. in politics and history from Brandeis University, where she now is a member of the Brandeis University Science Advisory Council. She also is on the board of trustees of the Keck Graduate Institute of the Applied Life Sciences. In 2005, the annual gathering of biotechnology chief executive officers at The Biotech Meeting in Laguna Niguel, Calif., inducted Karen into their Hall of Fame, citing her lifetime contribution to the biotech community. In 2007, Karen received a Special Recognition award at the American Liver Foundation's Salute to Excellence, honoring individuals who have made an outstanding contribution to biotechnology and medical innovation. In 2013, Karen was named one of Silicon Valley Business Journal's 100 most influential women.
 
Jeff Cranmer, Managing Editor, BioCentury
Jeff serves as Managing Editor of BioCentury. Since joining BioCentury in 2005, Jeff has also been Editor of BioCentury Extra and head of BioCentury's Research Group. Jeff has an A.B. from Princeton University and an M.A. from the Johns Hopkins School of Advanced International Studies.
 
Steve Edelson, Executive Editor, New Media
Steve, who serves as Executive Editor of New Media for BioCentury, has been a writer and editor for BioCentury since 1998, including as Executive Editor of SciBX and Editor of BioCentury Extra and as Senior Writer responsible for financial markets coverage. Steve has an M.S. in biotechnology from Northwestern University, where he also received a B.A. in biochemistry.
 
Simone Fishburn, Ph.D., Executive Editor, SciBX
Simone serves as BioCentury's Executive Editor in the SciBX joint publishing venture with Nature Publishing Group. Prior to joining BioCentury in 2013, Simone worked as a translational scientist in the biotech industry, including nine years in preclinical drug development at Nektar Therapeutics. Simone holds a Ph.D. in molecular pharmacology from the Weizmann Institute of Science in Israel, and an M.A. and B.A. in pharmacology from Cambridge University.
 
Erin McCallister, Senior Editor
Erin joined BioCentury in 2008. She previously was a program officer at The Great Lakes Protection Fund and a biologist at Dow AgroSciences LLC. She holds an M.Sc. in environmental science and policy from the University of Chicago and a B.S. in biology from Purdue University.
 
Tamra Sami, Senior Editor, News
Tamra joined BioCentury in 2014 after serving as managing editor of Elsevier Business Intelligence's PharmAsia News, which she helped launch in 2008 and where she recruited and managed a team of reporters across Asia and Australia.Prior to joining EBI, she was an executive editor with FDAnews.
 
Susan Schaeffer, Editor, BioCentury
Susan serves as Editor of BioCentury. She was previously Senior Editor in charge of Product Discovery & Development coverage from 2010 through 2012. She was Managing Editor of BioCentury and BioCentury Extra from 2004 through 2010. She joined BioCentury in 2003 after 10 years as an editor in the consumer packaged goods sector, including work with international strategy consultants Kurt Salmon Associates.
 
Steve Usdin, Senior Editor, Washington
Steve has been Washington Editor of BioCentury since 1993, and has spent the past 20 years in the nation's capital covering political and policy issues affecting the life sciences sector. He also is the host of BioCentury This Week, BioCentury's weekly public affairs television program, as well as BioCentury Senior Editor responsible for coverage of social issues involving biotechnology. Steve’s reporting about biotechnology and biomedical policy has been cited in The Economist, The Wall Street Journal, the Washington Post, New Scientist and other publications. In 2012, the FDA Alumni Association named Steve the Harvey W. Wiley Lecturer, making him the first journalist to receive the Wiley Award. His book, “Engineering Communism: How Two Americans Spied for Stalin and Founded the Soviet Silicon Valley,” was published in 2005 by Yale University Press.
 
Walter Yang, Director of Research
Walter, who directs BioCentury's editorial research effort, has been a Staff Writer and Research Analyst since joining the company in 1999. Walter previously worked as a researcher at the Salk Institute for Biological Studies. He holds a B.S. in molecular biology from the University of California, San Diego, and has a master's degree in accounting and finance from the London School of Economics and Political Science.
 

› Associate Editor

Michael J. Haas, Associate Editor
Mike joined BioCentury in 2007 after gaining nearly 14 years of experience as an analytical chemist and mass spectrometry group leader at DuPont, DuPont Merck, DuPont Pharma and Bristol-Myers Squibb. He holds an M.Sc. in chemistry from the University of Toronto and a B.S. in chemistry from the University of Delaware.
 
Stephen Hansen, Associate Editor
Stephen has been a writer and news editor for BioCentury since 2006. He holds B.A.s in biology and history from Bethel University and an M.Phil in history from Oxford University.
 

› Senior Writers

Emily Cukier-Meisner, Senior Writer
Emily joined BioCentury in 2013 after gaining over six years of experience in the analysis and classification of clinical-stage drug products at Brand Institute. Previously, she conducted studies of protein folding at the University of Chicago and University of Cincinnati. She holds a B.S. in chemistry from Harvey Mudd College and an M.S. from the University of Chicago in biochemistry and molecular biology.
 
Kai-Jye Lou, Senior Writer
Kai-Jye joined BioCentury in 2008 after completing a M.S. in biomedical engineering and B.S. in computational and systems biology at the University of California, Los Angeles. His past research projects have included developing control algorithms for stabilizing cardiac arrhythmias and building pharmacokinetic and pharmacodynamic models.
 
Catherine Shaffer, Senior Writer
Catherine joined BioCentury in 2014 with over a decade of experience reporting in the fields of science and biotechnology. Previously, she worked as a biochemist for Pfizer studying potential drug candidates for cancer and other diseases. She has a M.Sc. in Biological Chemistry from the University of Michigan and a B.Sc. in Biochemistry from Michigan State University.